Breakthrough technology for soft tissue regeneration of the anterior cruciate ligament (ACL) of the knee.
July 2010 – Soft Tissue Regeneration, Inc. closed a $4.0 million Series A round of financing and plans to begin European clinical trials in January 2011.
